Depth bar: Due-diligence dossier for Stamped outreach. Estimates marked [~]; directory facts [dir]; unverified claims [!]. Never invent bill numbers, court outcomes, or emails.

1. Company overview & snapshot

Laborate Pharmaceuticals India Ltd is a Panipat-founded, Bhatia-promoted branded-generics and OTC manufacturer with a strategically important multi-unit footprint at Paonta Sahib, Himachal Pradesh, plus Panipat and newer Karnal (ayurvedic/cosmetic) capacity. For Stamped, the Paonta campus (Units II, III, V) is the energy conversation: sterile/ophthalmic/injectable blocks, advanced HVAC and EU-GMP alignment. The hard commercial gate is which HT bill — Paonta HPSEBL vs Panipat Haryana DISCOM — clears the ≥ ₹30 lakh/month Band A floor.

1.1 Legal identity & corporate structure

CIN U24239HR1990PLC030835, ROC Delhi, unlisted public limited company; registered office E-11 Industrial Area, Panipat 132103. Authorised capital ~₹5 Cr, paid-up ~₹2.63 Cr [dir]. Open charges ~₹183.5 Cr [dir]. Whole-time Directors include Ajay Bhatia, Sanjay Bhatia, Parag Bhatia, Arpit Bhatia. CRISIL ratings reference (Apr 2025) note Crisil A/Stable / A1 facilities.

1.2 What they make & where money comes from

~1,500 formulations: injectables, eye drops, tablets/capsules, ointments, OTC, dermatology, emerging chronic portfolio; domestic elite/GPP/personal care verticals plus exports to Africa/MENA/Asia with EU push from Paonta. FY25 revenue ₹1,550 Cr (Tracxn); CRISIL cites ₹1,500–1,550 Cr run-rate. Facilities page lists high daily capacities (tablets 18.5M/day etc.) — capacity is not utilisation; ask which blocks run continuous HVAC for validated systems.

1.3 Plants, addresses & footprint

• Unit I: Panipat — WHO-GMP SVP/ophthalmic/solids.
• Unit II (2004): Paonta — GMP SVP/ophthalmic/solids/syrup/externals.
• Unit III (2010): Paonta — largest; separate beta-lactam / cephalosporin / general; EU/USFDA-standard claims.
• Unit IV (2023): Salwan, Karnal — ayurvedic/cosmetics.
• Unit V (2023): Satiwala, Paonta — newer EU-oriented blocks. Pilot site: highest-load Paonta HT account (likely Unit III/V cluster). Do not mix Panipat and Paonta invoices.

1.4 Leadership & CRM map

Shailinder Sharma — Plant Head Operations, Paonta (LinkedIn since Sep 2022) — primary champion. Ashim Kumar Dutta — SGM / Plant Head, Paonta (ex-Sun Pharma). Economic buyer may sit with Bhatia WTDs (Arpit for marketing/expansion narrative). Map electrical/utilities head and finance for bill release in call 1.

1.5 Recent news (24 months) & timing for Stamped

Pharma India Magazine / management interviews highlight Paonta EU-GMP investment, energy-efficient and environmentally conscious facility claims, automation and digital batch recording. CRISIL notes new plant primarily for Europe exports. Timing: utilities sized for regulated peaks → evidence-verified staging is timely; avoid “new HVAC hardware” pitch.

2. Energy profile

DISCOM / supply (name early): HPSEBL for Paonta Sahib / Sirmaur plants; UHBVN/DHBVN (or Haryana industrial feed) likely for Panipat — confirm on invoice. Never assume one DISCOM across states.

2.1 Bill band, tariff & demand

No public Paonta monthly bill. For multi-block sterile pharma at ₹1,550 Cr group scale with EU HVAC, Paonta alone may clear ₹30L+ [~] but lead report insists on qualifying Panipat vs Paonta HT. Ask: peak MD season (monsoon HVAC), concurrent steriliser/AHU starts, and whether Units share one consumer number.

2.2 Generation, fuel & renewables

DG typical for GMP plants. Solar/roof claims not central in public docs reviewed — ask. Boilers/steam for sterilisation if present create thermal↔electrical interaction but Stamped verifies electrical bill lines first.

2.3 EnMS, PAT, ISO, BRSR

WHO-GMP / country FDA approvals; EU-GMP narrative for Paonta. No confirmed ISO 50001 in searched materials. Unlisted — no BRSR. Data maturity likely BMS + validated utility monitoring without “prescriptive ₹ owner” layer.

2.4 Likely ₹ leak categories (hypothesis)

HVAC/chiller/AHU over-provisioning for audit peaks; coincident cleanroom starts; compressed air pressure drift; purified water / WFI support motors idle; PF; weekend validated-system “always on” without production. Never recommend de-validating or writing setpoints into BMS without QA path.

3. Operations, equipment & digital stack

3.1 Process flow & critical loads

Dispensing → granulation/compression or sterile filling → lyophilisation if any → packaging → QC → warehouse. Critical: HVAC, chillers, AHUs, compressors, purified water, lyophilisers/autoclaves, packing lines.

3.2 Shifts, seasonality, production pattern

Batch campaigns for export SKUs; EU audit windows may keep utilities at peak. Map changeover vs continuous HVAC load.

3.3 Automation, metering, SCADA/EMS/DCS

Management cites automation, digital batch recording, data-led monitoring. Path A plausible via BMS/meter export if QA/IT allow read-only. Path B: utility CSV + batch calendar.

3.4 Capex / tech projects affecting energy

Unit V 2023 and EU certification cycle — post-capex baseline moment. Stamped verifies operational use of installed utilities vs invoice, not hardware ROI for Laborate’s own investment.

4. Stamped Energy fit analysis

4.1 ICP scorecard

Geography: HP Paonta in North India outreach — pass if HT local. Vertical: pharma process — pass. Scale ₹1,550 Cr — pass. Bill gate — conditional on Paonta (or Panipat) invoice. Decision: plant head + promoters — medium.

4.2 Fit score rationale

8/10 for multi-unit EU HVAC intensity and named plant heads; deduction for dual-DISCOM qualification risk and unlisted bill opacity.

4.3 Wedge (parser-critical)

The strongest wedge is: Paonta EU-GMP HVAC and sterile-block start coincidence that inflates HPSEBL MD — prescribe staging with owners and verify with evidence after confirming Paonta (not Panipat) owns the pilot HT account.

4.4 Objections & competitors

“Validation forbids changes.” → no control writes; only schedule/owner recommendations inside existing validated envelopes. “We are energy efficient / certified.” → continuous evidence-verified M&V. Corporate Panipat purchase → insist plant electrical owns proof.

4.5 Pilot design

One Paonta HT consumer / feeder group. Success: one verified MD or energy line movement with QA-accepted operational change. Kill: wrong site bill, bill <₹30L, no OT export, no plant owner.

5. Before you reach out

5.1 Discovery checklist

• Paonta vs Panipat: which invoice ≥ ₹30L/mo?
• HPSEBL account name and CMD.
• Which unit (II/III/V) dominates kWh?
• BMS vendor and export rights.
• Chiller TR and AHU count (discovery, not claim).
• EU audit calendar next 90 days.
• Electrical/utilities head WhatsApp.
• QA constraint list for any schedule change.
• Two HT bills + any energy KPI pack.
• Approver for 90-day fee.

5.2 Do not lead with

• Do not lead with dashboards, AI or ESG-first.
• Do not propose BMS setpoint writes or dehumidification cuts that threaten GMP.
• Do not assume Panipat HQ email reaches Paonta plant.
• Do not conflate ayurvedic Unit IV energy with sterile Paonta.

5.3 Opening hooks

“EU-GMP Paonta utilities are often commissioned for peak audit load. We stay read-only, assign ₹ to avoidable HVAC/start overlap, and verify with evidence — after we confirm which HT account is Paonta.”

6. Risks, flags, controversies & sources

6.1 Integrity / controversy / regulatory (search explicitly)

• Search terms: Laborate Pharmaceuticals + FDA warning / Form 483 / recall / NGT / PCB / lawsuit / labour / tax raid / scam (2024–2026).
• No company-specific scandal or enforcement headline located in reviewed results beyond standard pharma regulatory operating risk. CRISIL commentary is credit-positive/stable.
• Country regulatory approvals list on facility page is marketing; not controversies.
• Open MCA charges (~₹183 Cr) are financing context, not misconduct.

6.2 Data quality flags

• Dual-state HT must be separated.
• Email inference for Shailinder/Ashim unconfirmed.
• Revenue is entity-level, not Paonta P&L.
• Helpdesk phone is national, not plant gate.

6.3 Sources consulted

• https://www.laborate.com/facility.php , board-of-directors.php
• CRISIL rating rationale Apr 2025; Tracxn / TheCompanyCheck profiles
• LinkedIn: Shailinder Sharma, Ashim Kumar Dutta, Arpit Bhatia
• Pharma India Magazine manufacturing interview on Paonta
• Lead report Punjab multi-vertical Jul 2026

Operating diligence addendum (meter → bill → owner)

A1. How to read the first two HPSEBL (Paonta) / UHBVN-DHBVN (Panipat) invoices

Ask the plant to share the latest two HT/EHT invoices with account name unredacted for legal matching, and demand/energy pages intact. Record: sanctioned or contract demand; billing demand; recorded maximum demand; power-factor reading and incentive/penalty line; ToD or peak/off-peak segmentation if present; fuel surcharge / electricity duty / municipal cess; any open-access or captive adjustment; and whether multiple meters roll into one consumer. Photograph or PDF the tariff category. Convert every line that can move with operational behaviour (MD, PF, ToD energy) into a ranked opportunity list — that list is the only list Stamped should sell into on day one.

For Paonta Sahib, the immediate commercial question is whether the consumer that matches the gate address is also the P&L that can approve a 90-day opex pilot. Many North India groups present a trading name on the gate and a different limited-company name on the bill. If they diverge, stop and re-paper the CRM record before proposing Scope of Work language.

A2. Process-specific measurement plan — EU-GMP HVAC, sterile filling, injectables/ophthalmics

Build a one-page event dictionary with the electrical owner: which start-up, hold, changeover, CIP, campaign or utility header historically coincides with bill pain. For each event type, ask (a) earliest safe start time, (b) whether the event can stagger versus a peer feeder, (c) what quality/safety interlock forbids delay, and (d) who today gets a WhatsApp if MD warns. Stamped’s value appears only when (d) exists — prescriptions without owners become another unread report.

Interval data preference order: (1) DISCOM 15-minute or AMI pull if available; (2) plant energy-meter logger CSV; (3) DCS/SCADA historian tags for large motors/utility headers; (4) daily energy + production register if interval is impossible. Never claim a percentage saving without production normalisation. Tonnes, batches, pairs, hours of sterile HVAC, or caustic MT are acceptable proxies depending on site.

A3. Path A vs Path B data access

Path A: read-only connection or scheduled export from existing EMS/SCADA/BMS/meter gateway; Stamped never writes setpoints. Path B: weekly CSV drops plus a shared campaign/production calendar. Either path must clear OT/IT security, retention, and need-to-know access. Expect an Indian industrial cyber questionnaire; answer in plain language — software layer, no PLC write, no remote control, bill verification.

If the site already paid for ISO 50001 consultants, VFDs, solar EPCs, or OEM analytics, acknowledge those spend lines explicitly. Stamped should be framed as the closure layer that turns residual observations into assigned rupees and invoice checks — not as a replacement capital project.

A4. 90-Day Bill Verification Program — local framing

Week 0: entity + bill + champion map. Weeks 1–2: baseline MD and energy components with production context. Weeks 3–8: weekly ranked prescription cards (max 5) with owner, due date, expected rupee line, and operational constraint. Weeks 9–12: reconcile executed cards to HPSEBL (Paonta) / UHBVN-DHBVN (Panipat) invoice components; document kill or expand. Commercial Band A working fee Rs 2–5 lakh [~] fixed for the proof — present as structured verification, not a discount pilot. Kill criteria: bill below ICP floor; no accessible data; no plant owner; unstable production without usable normalisation; zero controllable lever after two review cycles.

A5. Cluster and reference context

Field sequencing for this campaign batch should respect peer density: Mandi Gobindgarh steel day; Derabassi–Baddi–Rajpura chemistry day; Ghaziabad–Muzaffarnagar steel day; Kanpur–Unnao leather/packaging day. Peer references are for routing confidence, never for inventing shared bills. Keep each legal entity’s invoice private.

A6. Safety, quality and integrity boundaries

No outreach message may imply Stamped will change validated recipes, membrane current density, Tempcore quench parameters, sterile differential pressures, or tannery finish formulas. Those domains stay with process owners; Stamped only sequences and attributes cost to events inside already-approved envelopes. Controversies, historical tax matters, rating actions or inspections are pre-call awareness — they are not cold-call openers.

Hard gate: never start engineering until Paonta vs Panipat HT ownership is invoice-proven.

Extended call-prep narrative (Stamped field use)

B1. First 20 minutes of discovery

Open with process respect, not software. Confirm legal entity on the invoice, DISCOM name, and who owns the largest feeder MD event in the last 90 days. Ask for two invoices and one production calendar export before any platform demo. If the champion cannot produce bills within a week, treat the opportunity as stalled — Bill Verification Program without invoices is theatre. Record whether Path A (historian/meter export) or Path B (CSV) is realistic given OT policy. Confirm the economic buyer who can approve a Rs 2–5 lakh [~] fixed 90-day fee without a full ERP tender.

B2. Prescription card discipline

Every recommendation must name: event, owner, due date, expected rupee line on the DISCOM invoice, operational constraint, and evidence of execution. Cards without owners are deleted. Cap weekly cards at five so plant teams are not flooded. Prefer MD sequencing and idle-hold cuts before exotic tariff products. Never propose changing validated recipe, membrane current, sterile pressure, or Tempcore quench parameters. If quality or safety forbids a schedule change, mark the lever as blocked and move on — credibility beats aggressive savings claims.

B3. Verifying savings without gaming

A lower bill alone is not success if tonnes, pairs, or batches fell. Normalise against a production proxy agreed in week 1. Document holidays, forced outages, new-line commissioning, captive/solar settlement changes, and weather-sensitive HVAC. Keep a decision ledger shared with the plant: recommendation, owner, status, expected vs observed invoice delta. Present kill or expand at day 90 with the same ledger — this is how Stamped differs from audit PDFs that never close.

B4. Competitive and incumbent handling

If the site has EMS/SCADA/BMS, OEM analytics, ISO consultants, or solar EPCs, congratulate the spend and ask what residual bill lines still surprise them monthly. Position Stamped as the closure layer: rupee assignments and invoice reconciliation. Refuse head-to-head dashboard bake-offs. If Gujarat, Panipat, or Noida corporate IT appears, keep plant electrical as the proof owner and let corporate rubber-stamp after a verified bill line — not before.

B5. Geographic and cluster logistics

Batch 3 spans Mandi Gobindgarh, Paonta/Derabassi/Rajpura, Ghaziabad/Muzaffarnagar, and Kanpur–Unnao. Plan field days by corridor. Carry printed one-pagers: Fit score, DISCOM hypothesis, strongest wedge sentence, and two discovery questions. After each visit, update extras field intel — especially corrected phones, electrical names, and whether the bill cleared Rs 30 lakh/month.

B6. Messaging hygiene for this batch

Owner-operated steel/leather accounts tolerate Hindi-friendly WhatsApp and short calls. Listed pharma/chemical accounts prefer email plus LinkedIn with technical depth. Never open with controversies (GST/Excise history, EuGMP observations, rating actions) — those are internal briefings only. Always name DISCOM early in research-backed prep sheets so call-prep UI can render correctly.

6.4 Evidence discipline and next research actions

This dossier separates three evidence classes. Verified public facts come from corporate websites, MCA aggregators, annual/BRSR filings, rating rationales, court databases and named LinkedIn profiles. Directional operating hypotheses use disclosed process profiles to decide what to check on the first call; they are not allegations of failure. Commercial estimates—especially monthly electricity spend—remain labelled [~] until the site provides a current HT invoice and production context.

Immediate sequence after first contact: (1) verify legal entity and invoice ownership; (2) collect two DISCOM invoices and document tariff, demand and PF lines; (3) identify the top three load events with the electrical/utility owner; (4) map production or quality constraints that cannot move; (5) agree the smallest controllable boundary for a 90-day trial. Security and governance: confirm permitted interface (historian export, meter CSV, secure file exchange) plus retention and OT approvals. No proposal implies PLC/DCS writes, recipe changes or unapproved remote control.

Treat adverse information proportionately. A negative search is not clearance that no legal, environmental, labour or financial issue exists. When a named proceeding exists, cite source, date, procedural status and exact entity; do not imply guilt or current business impact without reliable evidence. Re-check material sources and contact tenure immediately before a campaign send.